Blue Jet Healthcare reported a weak performance in its September quarter (Q2 FY25) results. The company’s net profit fell 10.8% year-on-year to ₹52 crore, compared to ₹58.3 crore in the same period last year.
Revenue also declined 20.6% YoY to ₹165.4 crore, against ₹208.2 crore a year ago, reflecting subdued business momentum. EBITDA dropped 21% to ₹55 crore, while margins remained largely stable at 33.1% versus 33.3% YoY, indicating cost discipline despite lower sales.
Following the results, Blue Jet Healthcare shares fell over 8%, trading lower amid weak investor sentiment. The stock opened at ₹680, hit a high of ₹688.50 and a low of ₹617.45 during the session. The company’s 52-week high stands at ₹1,027.80, while the 52-week low is ₹468.50.
Disclaimer: This article is for informational purposes only. It is not intended to be investment advice or a recommendation to buy or sell any stock. Readers are advised to consult their financial advisor before making any investment decisions.
